| | | | | |
AMPH Amphastar Pharmaceuticals, Inc. | $20,1000 | -0,40% | $960,34M | $422,00K | |
REPL Replimune Group, Inc. | $11,2200 | +1,36% | $960,31M | $2,97M | |
| $56,3100 | +0,21% | $957,77M | $138,53K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | $27,6600 | -1,46% | $957,06M | $78,71K | |
AVTX Avalo Therapeutics, Inc. Common Stock | $17,3050 | -6,39% | $956,69M | $1,85M | |
HSLV Highlander Silver Corp. | $4,6500 | -0,22% | $956,09M | $174,51K | |
| $55,8000 | +1,62% | $955,17M | $137,41K | |
SANA Sana Biotechnology, Inc. Common Stock | $3,5700 | +2,29% | $951,75M | $2,87M | |
ABX Abacus Global Management, Inc. | $11,6700 | +8,96% | $950,59M | $1,04M | |
ANRO Alto Neuroscience Inc. | $24,9400 | -5,49% | $948,94M | $378,16K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | $3,0550 | +6,08% | $948,29M | $2,06M | |
RHLD Resolute Holdings Management, Inc. | $143,66 | -0,60% | $948,28M | $283,28K | |
BTZ BlackRock Credit Allocation Income Trust | $10,2200 | +0,00% | $948,17M | $244,11K | |
DBVT DBV Technologies S.A. | $15,8100 | -3,60% | $947,57M | $266,20K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | $13,6250 | -1,91% | $947,08M | $4,57K | |
